Keyword: Horizon Pharma

Just how expensive can pharmacy medicines get? As much as a buying a luxury car every month, according to GoodRx's latest ranking.

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

It's a new year, which means it's a new opportunity for drugmakers hoping to pass FDA muster for new therapies––some of which have blockbuster hopes.

As it awaits an FDA review of its eye disease candidate, Horizon is balling out on a massive facility in the heart of San Francisco's biotech hub.

Horizon Therapeutics’ latest awareness campaign looks to draw attention to thyroid eye disease and create social media communities for those affected.

Horizon Therapeutics is preparing for the potential launch of inflammatory eye drug teprotumumab with team building.

Horizon Therapeutics launched Gout Lies, a new doctor-oriented campaign to highlight research and new developments about the chronic disease.

The most expensive drugs in the U.S. feature commercial hits as well as lesser-known ones, with several Big Pharma products in the mix.

Repeated drug price hikes have caught plenty of criticism lately, but the attention isn't dissuading everyone.

Payer discounts are likely to grow even if midterm elections revive attacks on the industry—and investors should be worried about that, analysts say.